CD96 and neoplasm: Interestingly, the expression of failure-associated checkpoint molecules such as PD-1, CD96, and TIGIT on CD49a+ NK cells within the tumor is upregulated, allowing tumor cells to escape from immune surveillance, and CD49a+ NK cell accumulation in liver tumor tissue is associated with disease progression and poor prognosis (67).